Author Affiliations: Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran, Victoria, Australia (Ms O’Neil); and Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia (Dr Sanderson).
Gulliksson et al1 report the results of a randomized controlled trial of cognitive behavioral therapy (CBT), measuring its effects on Cardiovascular Disease (CVD) recurrence in 362 patients with coronary artery disease. The authors found that, after 94 months, the CBT group had a 41% lower rate of fatal and nonfatal recurrent CVD events and 45% fewer recurrent acute myocardial infarctions (AMIs) after adjustment for covariates.
O'Neil AE, Sanderson K. The Use of Cognitive Behavioral Therapy for Secondary Prevention in Patients With Coronary Heart Disease. Arch Intern Med. 2011;171(16):1506-1507. doi:10.1001/archinternmed.2011.388